Skip to main content

Table 3 Incidence of asthma attacks and clinical symptoms

From: Association between Asian dust exposure and respiratory function in children with bronchial asthma in Nagasaki Prefecture, Japan

 

Goto Islands

South Nagasaki

2014

2015

2016

2014

2015

2016

Number of PEFR measurements

 Total peak flow days

2242 (100)

2023 (100)

1731 (100)

4286 (100)

4649 (100)

4678 (100)

Asthma attack defined by PEFR reduction*

 Mild (person day) (%)

428 (19.1)

358 (17.7)

554 (32.0)

1080 (25.2)

1011 (21.8)

729 (15.6)

 Moderate (person day) (%)

115 (5.1)

158 (7.8)

232 (13.4)

289 (6.7)

309 (6.7)

216 (4.6)

 Severe (person day) (%)

44 (1.9)

73 (3.6)

58 (3.4)

59 (1.4)

68 (1.5)

62 (1.3)

Self-reported respiratory symptoms

 Self-reported attacks

  0: None

2183 (87.9)

1802 (81.6)

2015 (91.3)

4156 (88.6)

4800 (91.5)

4910 (92.0)

  1: Attack without dyspnea

221 (8.9)

339 (15.4)

92 (4.2)

457 (9.7)

379 (7.2)

329 (6.2)

  2: Attack with little dyspnea

68 (2.7)

60 (2.7)

99 (4.5)

75 (1.6)

59 (1.1)

82 (1.5)

  3: Attack with much dyspnea

12 (0.5)

7 (0.3)

2 (0.1)

3 (0.1)

6 (0.1)

15 (0.3)

 Attack in exercise (person day) (%)

33 (1.3)

69 (3.1)

9 (0.4)

47 (1.0)

165 (3.2)

82 (1.5)

 Sleep disturbance (person day) (%)

22 (0.9)

19 (0.9)

21 (1.0)

24 (0.5)

24 (0.5)

37 (0.7)

 The usage of the inhalants (person day) (%)

110 (4.4)

159 (7.2)

79 (3.6)

276 (5.9)

152 (2.9)

231 (4.3)

 The usage of the oral medicine (person day) (%)

69 (2.8)

200 (9.1)

29 (1.3)

178 (3.8)

141 (2.7)

155 (2.9)

 Emergency visits (person day) (%)

14 (0.6)

23 (1.0)

11 (0.5)

11 (0.2)

17 (0.3)

20 (0.4)

 Either symptoms (person day) (%)**

401 (16.1)

604 (27.4)

263 (11.9)

730 (15.6)

571 (10.9)

637 (11.9)

 Self-reported other symptoms

 Skin (person day) (%)

93 (3.7)

375 (17.0)

146 (6.6)

573 (12.2)

742 (14.2)

442 (8.3)

 Eye (person day) (%)

371 (14.9)

283 (12.8)

188 (8.5)

493 (10.5)

463 (8.8)

444 (8.3)

 Nose (person day) (%)

562 (22.6)

863 (39.1)

699 (31.7)

1020 (21.7)

1310 (24.9)

1002 (18.8)

 Either symptoms (person day) (%)***

797 (32.1)

1044 (47.3)

793 (35.9)

1390 (29.6)

1875 (35.8)

1460 (27.3)

  1. *Base on the personal best peak expiratory flow rate of every month
  2. **Secondary outcome related to respiratory symptoms
  3. ***Secondary outcome related to other than respiratory symptoms